Accepted for Publication: September 10, 2014.
Published Online: January 14, 2015. doi:10.1001/jamadermatol.2014.3689.
Study concept and design: Eriksson, Zebary, Hansson.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Eriksson, Zebary, Ghaderi.
Critical revision of the manuscript for important intellectual content: Eriksson, Zebary, Vassilaki, Omholt, Hansson.
Statistical analysis: Eriksson, Zebary.
Obtained funding: Eriksson, Hansson.
Administrative, technical, or material support: Eriksson, Zebary, Ghaderi.
Study supervision: Vassilaki, Hansson.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was supported in part by grants CAN 2010/225 and CAN 2011/883 from the Swedish Cancer Society (Dr Hansson), grants 124083 and 124092 from Radiumhemmet Research Funds (Dr Hansson), grant 20100032 from the Stockholm County Council (Dr Hansson), grant 1107/2012:1 from the Welander-Finsen Foundation (Dr Eriksson), grant 2013lund37185 from the Robert Lundberg Memorial Foundation (Dr Eriksson), grant LA2013-0199 from the Sigurd and Elsa Goljes Memorial Foundation (Dr Eriksson), and the Ministry of Higher Education and Scientific Research in Iraqi-Kurdistan Regional Government (Dr Zebary).
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Additional Contributions: David Capper, MD, and Andreas von Deimling, MD, PhD, at Heidelberg University provided the VE1 antibodies. Ann Olsson at the Department of Pathology, Karolinska University Hospital Solna, and Marianne Frostvik-Stolt provided help with the immunohistochemical analysis.
Correction: This article was corrected January 22, 2015, for an error in an author affiliation.